This topic contains a solution. Click here to go to the answer

Author Question: What percentage of total face-to-face time must be exceeded during the encounter to make time the ... (Read 70 times)

wrbasek0

  • Hero Member
  • *****
  • Posts: 560
What percentage of total face-to-face time must be exceeded during the encounter to make time the controlling factor to qualify for a particular level of E/M service?
 
  A) 40
  B) 50
  C) 60
  D) 70

Question 2

When billing E/M services on the CMS-1500 form or 837P electronic claim, each CPT code must be associated with what identifier?
 
  A) length of time
  B) place of service
  C) type of patient
  D) level of care



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lolol

  • Sr. Member
  • ****
  • Posts: 330
Answer to Question 1

Answer: B

Answer to Question 2

Answer: B




wrbasek0

  • Member
  • Posts: 560
Reply 2 on: Jun 27, 2018
Gracias!


mjenn52

  • Member
  • Posts: 351
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Children of people with alcoholism are more inclined to drink alcohol or use hard drugs. In fact, they are 400 times more likely to use hard drugs than those who do not have a family history of alcohol addiction.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library